Physician profile
David A Schmid
NPI 1801483557
$1,080.54
in general payments reported to CMS, 2019-2025
18 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $270 · 2023: $286 · 2024: $49.27 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.81 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $140.85 | 2023-2025 | Airsupra, Fasenra |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2023 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $124.87 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $122.11 | 2022 | |
| Baxter Healthcare | $91.30 | 2022-2025 | Hillrom - Monarch Airway Clearance System |
| Vertex Pharmaceuticals Incorporated | $81.31 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $72.45 | 2021 | |
| Abbvie INC. | $51.27 | 2021-2022 | |
| Electromed, INC. | $42.22 | 2023 | Smartvest |
| Nestle Healthcare Nutrition INC. | $36.10 | 2022 | |
| Amgen INC. | $34.00 | 2025 | |
| Gilead Sciences, INC. | $33.21 | 2021-2022 | |
| Viatris Specialty LLC | $31.14 | 2025 | Tobi Podhaler |
| Philips North America LLC | $25.31 | 2024 | (Ak6) Vest Therapy |
| Fisher & Paykel Healthcare INC | $23.96 | 2024 | Fisher & Paykel Healthcare |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $19.11 | 2023 | Yupelri |
| Aimmune Therapeutics, INC. | $13.70 | 2025 | Zenpep |
| Genentech USA, INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schmid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.